抗HIV治療ガイドライン(2022年3月発行)

XIV急性HIV感染症とその治療

文献

  1. Cohen MS, Shaw GM, McMichael AJ, et al. Acute HIV-1 Infection. N Engl J Med. 364: 1943-54, 2011.
  2. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV (米国DHHS、Jan 20, 2022).
    https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/whats-new-guidelines
  3. Saag MS, Gandhi RT, Hoy JF, et al. Antiretroviral Drugs for treatment and Prevention of HIV infection in Adults: 2020 recommendations of the International Antiviral Society-USA Panel. JAMA. 324: 1651-1669, 2020.
  4. BHIVA guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 (2016 interim update)
    https://www.bhiva.org/HIV-1-treatment-guidelines.
  5. European AIDS clinical society (EACS) guidelines (Version 11.0, Octomber 2021) (https://eacs.sanfordguide.com)
  6. Principles and practice of Infectious Disease. Mandell, Douglas, and Bennett’s 9th edition, 1659-60, 2019.
  7. Chu C and Selwyn PA. Diagnosis and initial management of acute HIV infection. Am Fam Physician. 81: 1239-44, 2010.
  8. 診療におけるHIV-1/2感染症診断ガイドライン2020版, 日本エイズ学会・日本臨床検査医学会 標準推奨法 (https://jaids.jp/wpsystem/wp-content/uploads/2020/10/guidelines.pdf)
  9. Kondo M, Sudo K, Sano T, et al. Comparative evaluation of the Geenius HIV 1/2 Confirmatory Assay and the HIV-1 and HIV-2 Western blots in the Japanese population. PLoS ONE 13: e0198924, 2018.
  10. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272: 1167-70, 1996.
  11. INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 373: 795-807, 2015.
  12. TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, et al. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 373: 808-22, 2015.
  13. Cohen MS, Chen YQ, McCauley M, et al.; HPTN 052 Study Team. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 375: 830-9, 2016.
  14. Rodger AJ, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 393: 2428-2438, 2019.
  15. 菊地 正、西澤雅子、小島潮子ら. 国内新規診断未治療HIV感染者・AIDS患者における薬剤耐性HIV-1の動向. 第35回日本エイズ学会学術集会・総会、抄録番号O-C08-01. 日本エイズ学会誌. 23(4): 422, 2021.
  16. HIV薬剤耐性検査ガイドライン ver, 10(平成28年度 日本医療研究開発機構 エイズ対策実用化研究事業「国内流行HIV及びその薬剤耐性株の長期的動向把握に関する研究」班)(https://www.hiv-resistance.jp/resistance04.htm)
  17. Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med. 379: 979-81, 2018.
  18. Zash R, Holmes L, Diseko M, et al. Neural-tube defects and antiretroviral treatment regimens in Botswana. N Engl J Med. 381: 827-40, 2019.
  19. Zash R, Holmes L, Diseko M, et al. Update on neural tube defects with antiretroviral exposure in the Tsepamo study, Botswana. 23rd International AIDS Conference 2020. #OAXLB0102.
  20. Pereira GFM, Kim A, Jalil EM, et al. Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study. Lancet HIV 8: e33-e41, 2021.
  21. Lockman S, Brummel SS, Ziemba L, et al. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet 397:1276-1292, 2021.
  22. Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States. (米国DHHS、Feb. 10, 2021).
    https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new-guidelines.
  23. Lisziewicz J, Rosenberg E, Lieberman J, et al. Control of HIV despite the discontinuation of antiretroviral therapy. N Engl J Med. 340: 1683-4, 1999.
  24. Lori F. and Lisziewick J. Structured Treatment Interruption for the Management of HIV Infection. JAMA 286: 2981-7, 2001.
  25. Hecht FM, Wang L, Collier A, et al. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis. 194: 725-33, 2006.
  26. SPARTAC Trial Investigators, Fidler S, Porter K, Ewings F, et al. Short-course antiretroviral therapy in primary HIV infection. N Engl J Med. 368: 207-17, 2013.
  27. Stöhr W, Fidler S, McClure M, et al. Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy. PLoS One. 8: e78287, 2013.

PAGE TOP